The Day One team is excited to be at the 29th Annual Meeting of the Society for Neuro-Oncology in Houston this week! Stop by our booth (423) to hear how we're redefining what's possible for people of all ages living with cancer. Investigators from the phase 2 FIREFLY-1 trial will be presenting data on Friday, November 22. See poster presentation details below. Learn more: https://bit.ly/4eqA1vg
Day One Biopharmaceuticals
生物技术研究
Brisbane，California 16,611 位关注者
Cancer drug development comes of age.
关于我们
Day One Biopharmaceuticals understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. We are a unique company created to find and develop new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. Our distinctive approach, together with our trusted network of pediatric oncology investigators, gives us an unparalleled ability to advance promising discoveries for patients of any age. We are ready to pursue the full potential of our therapies to improve the greatest number of lives as quickly as possible.
- 网站
-
https://www.dayonebio.com
Day One Biopharmaceuticals的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Brisbane，California
- 类型
- 上市公司
- 创立
- 2018
- 领域
- Oncology、Cancer、Drug Development、Biotechnology、Pediatric Oncology、Targeted Therapies、MAPK、Neuro-Oncology、Glioma、Childhood Cancer、Translational Medicine、Hematology和Glioma
地点
-
主要
获取路线
2000 Sierra Point Pkwy
US，California，Brisbane，94005
Day One Biopharmaceuticals员工
动态
-
Today, Day One announced that Co-Founder and Head of R&D, Dr. Samuel Blackman, MD, PhD, will be retiring from the company at the end of 2024. Read more here: https://bit.ly/3V0tccH Samuel Blackman we thank you for your passion, commitment, and visionary leadership to not only build and bring Day One to what it is today, but to help transform the treatment landscape for children and families impacted by cancer.
-
-
We’re looking forward to attending the Piper Sandler Annual Healthcare Conference. Day One management will participate in a fireside chat on Tuesday, December 3 at 3:00 PM ET. A live webcast of the discussion will be available here: https://bit.ly/3UMCys7 Learn more: https://bit.ly/3URzxqv
-
-
We are excited to announce that Adam Dubow, General Counsel, has been elected to the Healthcare Businesswomen’s Association 2025 Global Board of Directors. Thank you, Adam, for your continued commitment to help further the advancement and impact of women in the #healthcare business community. Learn more: https://bit.ly/4hOgGXm #HBAimpact
-
-
November is National Family Caregivers Month, a time to honor the strength and compassion of those caring for loved ones. We join with the community in raising awareness and supporting resources caregivers need as they navigate this journey. Connecting with others who share similar experiences can be a powerful source of comfort and knowledge. Our webinar series highlights personal stories from caregivers, non-profits, and healthcare providers, on caring for a child with pediatric low-grade glioma (pLGG). To listen and learn more, visit: https://bit.ly/3XxK1gN #NationalFamilyCaregiversMonth #CaregiversMonth
-
-
We’re honored to announce that Day One has been named as the 2024 Pantheon Award winner in the BioPharma category by California Life Sciences (CLS)! This award recognizes California’s leading pharmaceutical and biotech companies making exceptional contributions to the life sciences industry. This recognition reflects our commitment to creatively and intentionally develop new medicines for people of all ages with cancer. We’re proud to be part of such a vibrant life sciences community, working alongside other trailblazers committed to advancing science and patient care. Thank you, California Life Sciences (CLS), for this honor and for hosting such a wonderful event. Congratulations to all the winners!
-
-
Day One reports third quarter 2024 financial results. Read more: https://lnkd.in/gma97gYD
-
-
#WeAreHiring: Day One is looking for an experienced attorney to provide support to our Research & Development organization and who has extensive experience in drafting and negotiating R&D agreements and other types of contracts. Learn more about the position and apply today! View details here: https://lnkd.in/grP76DuN
-
-
Day One Co-founder and Head of R&D, Samuel Blackman, recently joined Tony Martignetti, MBA, PCC on The Virtual Campfire Podcast to reflect on his career in drug development. Sam shares his experiences, the humbling nature of his work, and the immense human effort behind creating new medicines. Listen to the full podcast here: https://lnkd.in/geXxP7WW
-